News & Events - Page 11 of 21 - Bay City Capital

Filters

Portfolio News

November 2, 2015

EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer

Portfolio News

October 27, 2015

EnteroMedics Publishes 2-Year Results of Its vBloc DM2 Study in the Journal of Obesity Surgery

Portfolio News

October 19, 2015

Nicox Announces Reverse Stock Split

Events

September 23, 2015

PE/VC Finance & Compliance Forum

Panel: LP relations: reporting & beyond
Kirby Bartlett
October 6-7, 2015
San Francisco, CA

Events

September 23, 2015

Immunogenomics 2015

Shaping the Future of Human Health
Merv Turner and Ashley Dombkowski
September 28-30, 2015
Huntsville, AL

Portfolio News

September 10, 2015

Dermira Presents New Data for DRM01 at International Dermatology Meeting

Portfolio News

September 3, 2015

Tria Beauty Names New General Manager North America & Vice President, Global Marketing

Portfolio News

August 26, 2015

Merus Enters Into € 72.8 million Series C Financing

Portfolio News

August 25, 2015

EnteroMedics CEO, Founder, and Chairman, Mark Knudson, to Retire

Portfolio News

August 24, 2015

Epizyme (EPZM) Announces FDA Acceptance of IND for Tazemetostat

Bay City Capital News

August 17, 2015

Forbes Opinion Co-authored by David Beier

Desperately Seeking Price Reform: Pharma Needs To Embrace Transparency & Value To Protect Innovation

Portfolio News

August 11, 2015

Dermira Announces Closing of Follow-on Public Offering of Common Stock

Portfolio News

August 10, 2015

Merus Prevails in Inequitable Conduct Case Against Regeneron

Portfolio News

August 6, 2015

Vtesse, Inc. Announces Preliminary Data from Ongoing Phase 1 Study of VTS-270 for Treatment of Niemann-Pick Disease

Portfolio News

August 5, 2015

Epizyme Appoints Robert Bazemore President and Chief Executive Officer